Parotid and submandibular botulinum toxin A injections for sialorrhoea in children with cerebral palsy
Authors:
- 1 November 2006
- journal article
- Published by Wiley in Developmental Medicine & Child Neurology
- Vol. 48 (11) , 883-887
Abstract
The aim of this study was to determine whether botulinum toxin A (BTX‐A) injected into the parotid and submandibular salivary glands of children aged 6 to 16 years with cerebral palsy (CP) and relative sialorrhoea significantly decreases their drooling and improves their quality of life. Twenty children (10 males, 10 females; mean age 10y 1mo [SD 3y 8mo]; range 6y 1mo‐16y 7mo) with CP, identified as having significant daily drooling (scoring at least 6 on drooling frequency/severity scales) were recruited. BTX‐A (2U/kg; maximum 70U) was injected under sedation, using ultrasound guidance (1.4U/kg and 0.6U/kg divided between parotid and submandibular glands respectively). Nineteen children completed the study: 15 with spastic quadriplegia (Gross Motor Function Classification System [GMFCS] Level V); one with dystonia (GMFCS Level V); one with hemiplegia (GMFCS Level II); and two with a mixed pattern of CP (GMFCS Levels III and V). Drooling was assessed by five methods at baseline, and 4 and 12 weeks after injection. Qualitative assessment of drooling frequency and severity scores showed statistically significant reductions at 4 weeks (p≤0.001) and 12 weeks (p=0.006). Qualitative assessment of quality of life scores (rated by parents and teachers separately) also significantly improved (p≤0.001 and P=0.023 respectively). Quantitative assessments showed that the number of bibs/scarves changed per day was significantly reduced at 4 weeks (p≤0.001). There was no side effect from the injections themselves; 89% of parents and children wished for further intrasalivary BTX‐A injections in the future. We conclude that percutaneous intrasalivary BTX‐A injections into the parotid and submandibular salivary glands can reduce drooling in children with CP and relative sialorrhoea, leading to an improvement in their quality of life.Keywords
This publication has 20 references indexed in Scilit:
- Effectiveness of the Innsbruck Sensori‐motor Activator and Regulator in improving saliva control in children with cerebral palsyDevelopmental Medicine & Child Neurology, 2004
- A systematic review for evidence of efficacy of anticholinergic drugs to treat droolingArchives of Disease in Childhood, 2003
- Prevalence of drooling in children with cerebral palsy attending special schoolsDevelopmental Medicine & Child Neurology, 2003
- Up-to-date report of botulinum toxin therapy in patients with drooling caused by different etiologiesJournal of Oral and Maxillofacial Surgery, 2003
- The Treatment of Drooling by Ultrasound‐Guided Intraglandular Injections of Botulinum Toxin Type A Into the Salivary GlandsThe Laryngoscope, 2003
- Successful Management of Drooling with Botulinum Toxin A in Neurologically Disabled ChildrenNeuropediatrics, 2002
- Clinical Study of Botulinum‐A Toxin in the Treatment of Sialorrhea in Children With Cerebral PalsyThe Laryngoscope, 2002
- Dental health of children with cerebral palsy following sialodochoplastySpecial Care in Dentistry, 1995
- SWALLOWING DISTURBANCES ASSOCIATED WITH DROOLING IN CEREBRAL‐PALSIED CHILDRENDevelopmental Medicine & Child Neurology, 1993
- DROOLING IN THE DEVELOPMENTAL DISABLED: MANAGEMENT PRACTICES AND RECOMMENDATIONSDevelopmental Medicine & Child Neurology, 1992